Novartis Institutes For Bio Medical Research, Inc. Intellia Therapeutics, Inc. (NTLA) insider trading activity

Novartis Institutes For Bio Medical Research, Inc. is > 10% Shareholder of Intellia Therapeutics, Inc.. Currently has a direct ownership of 4.13 Million shares of NTLA, which is worth approximately $50.3 Million. The most recent transaction as insider was on Dec 12, 2017, when has been sold 1,523,000 shares (Common Stock) at a price of $18.3 per share, resulting in proceeds of $27,870,899. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.13M

0% 3M change

0% 12M change

Total Value Held $50.3 Million

Novartis Institutes for BioMedical Research, Inc. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 12 2017	SELL Open market or private sale	$27,870,899 $18.3 p/Share	1,523,000 Reduced 26.94%	4,129,903 Common Stock
Mar 03 2017	BUY Other acquisition or disposition	-	79,245 Added 1.38%	5,652,903 Common Stock
May 11 2016	BUY Open market or private purchase	$4,999,986 $18.0 p/Share	277,777 Added 4.75%	5,573,658 Common Stock
May 11 2016	BUY Conversion of derivative security	-	5,295,881 Added 50.0%	5,295,881 Common Stock

Also insider at

FIXX

Homology Medicines, Inc. Healthcare

> 10% Shareholder

SURF

Surface Oncology, Inc. Healthcare

> 10% Shareholder

NIf